Education
About Us
Working with TipRanks
Follow Us
Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
Total Valuation
Rhythm Biosciences Ltd. has a market cap or net worth of AU$18.84M. The enterprise value is AU$14.28M.
Market CapAU$18.84M
Enterprise ValueAU$14.28M
Share Statistics
Rhythm Biosciences Ltd. has 289,846,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding289,846,740
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rhythm Biosciences Ltd.’s return on equity (ROE) is -7.91 and return on invested capital (ROIC) is -519.78%.
Return on Equity (ROE)-7.91
Return on Assets (ROA)-4.51
Return on Invested Capital (ROIC)-519.78%
Return on Capital Employed (ROCE)-7.01
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.11
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Rhythm Biosciences Ltd. is -2.00. Rhythm Biosciences Ltd.’s PEG ratio is 0.10.
PE Ratio-2.00
PS Ratio0.00
PB Ratio15.80
Price to Fair Value15.80
Price to FCF-2.20
Price to Operating Cash Flow-2.23
PEG Ratio0.10
Income Statement
In the last 12 months, Rhythm Biosciences Ltd. had revenue of 1.69M and earned -6.86M in profits. Earnings per share was -0.03.
Revenue1.69M
Gross Profit-1.36M
Operating Income-6.71M
Pretax Income-8.55M
Net Income-6.86M
EBITDA-6.80M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -2.12M and capital expenditures -1.59K, giving a free cash flow of -2.12M billion.
Operating Cash Flow-2.12M
Free Cash Flow-2.12M
Free Cash Flow per Share>-0.01
Dividends & Yields
Rhythm Biosciences Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.89
52-Week Price Change-25.00%
50-Day Moving Average0.08
200-Day Moving Average0.08
Relative Strength Index (RSI)23.57
Average Volume (3m)218.07K
Important Dates
Rhythm Biosciences Ltd. upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 20, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Rhythm Biosciences Ltd. as a current ratio of 1.58, with Debt / Equity ratio of 3.25%
Current Ratio1.58
Quick Ratio1.58
Debt to Market Cap0.00
Net Debt to EBITDA0.08
Interest Coverage Ratio-2.13K
Taxes
In the past 12 months, Rhythm Biosciences Ltd. has paid -1.69M in taxes.
Income Tax-1.69M
Effective Tax Rate0.20
Enterprise Valuation
Rhythm Biosciences Ltd. EV to EBITDA ratio is -1.94, with an EV/FCF ratio of -2.11.
EV to Sales7.78
EV to EBITDA-1.94
EV to Free Cash Flow-2.11
EV to Operating Cash Flow-2.14
Balance Sheet
Rhythm Biosciences Ltd. has AU$4.45M in cash and marketable securities with AU$158.66K in debt, giving a net cash position of -AU$4.30M billion.
Cash & Marketable SecuritiesAU$4.45M
Total DebtAU$158.66K
Net Cash-AU$4.30M
Net Cash Per Share-AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 71.87%, with operating margin of -396.84%, and net profit margin of -405.69%.
Gross Margin71.87%
Operating Margin-396.84%
Pretax Margin-505.69%
Net Profit Margin-405.69%
EBITDA Margin-402.09%
EBIT Margin-408.60%
Analyst Forecast
The average price target for Rhythm Biosciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast76.17%